Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
28.9M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
19.9M
-
Shares change
-
+1.12M
-
Total reported value, excl. options
-
$573M
-
Value change
-
+$35.3M
-
Number of buys
-
53
-
Number of sells
-
-28
-
Price
-
$28.87
Significant Holders of LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ) as of Q4 2024
102 filings reported holding LENZ - LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q4 2024.
LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.9M shares
of 28.9M outstanding shares and own 68.81% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.18M shares), Alpha Wave Global, LP (3.61M shares), VANGUARD GROUP INC (1.18M shares), BlackRock, Inc. (1.16M shares), 72 Investment Holdings, LLC (1.02M shares), Samsara BioCapital, LLC (987K shares), SECTORAL ASSET MANAGEMENT INC (977K shares), RTW INVESTMENTS, LP (863K shares), PRICE T ROWE ASSOCIATES INC /MD/ (823K shares), and Point72 Asset Management, L.P. (784K shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.